Related Experiment Video
Updated: Feb 19, 2026
17:16
Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
Published on: December 9, 2010
10.9K
MRI visualization of neuroinflammation using VCAM-1 targeted paramagnetic micelles
Francesca Garello1, Amerigo Pagoto1, Francesca Arena1
1Molecular & Preclinical Imaging Centers, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
Nanomedicine : Nanotechnology, Biology, and Medicine
|October 29, 2017
Summary
Researchers developed novel MRI-detectable micelles targeting VCAM-1 for early neuroinflammation detection. This innovative imaging probe shows promise for diagnosing neurodegenerative diseases and future theranostic applications.
Area of Science:
- Neuroimaging
- Nanomedicine
- Molecular Imaging
Background:
- Neuroinflammation is a key factor in neurodegenerative diseases.
- Vascular Cell Adhesion Molecule-1 (VCAM-1) is upregulated at the blood-brain barrier during neuroinflammation.
- Non-invasive imaging is crucial for studying disease onset and progression.
Purpose of the Study:
- To test MRI-detectable micelles targeted to VCAM-1 for visualizing neuroinflammation.
- To assess the efficacy of VCAM-1 targeted micelles in a mouse model of acute neuroinflammation.
- To evaluate the potential for diagnostic and theranostic applications.
Main Methods:
- Development of VCAM-1 targeted MRI-detectable micelles.
- Testing in a mouse model of acute neuroinflammation.
- Comparison with untargeted micelles and MultiHance (a clinical contrast agent).
Main Results:
- The VCAM-1 targeted micelles enabled early detection of neuroinflammation.
- Achieved higher T1 signal enhancement and more precise localization compared to controls.
- The nanosystem demonstrated a long blood half-life (approx. 6.3 hours), ensuring accumulation in inflamed areas.
Conclusions:
- Targeted micelles are effective for early detection and precise localization of neuroinflammation.
- The developed nanosystem shows potential for future diagnostic and theranostic applications in neurodegenerative diseases.
- Further development could enable drug delivery for neuroprotection or cancer therapy.
